Natco Pharma soars after Mylan settles Ozempic patent dispute 0 07.10.2024 12:58 Business Standard Natco Pharma rose 3.39% to Rs 1400.60 after the company announced a settlement in the U.S. patent litigation for generic Ozempic. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
